Incara's catalytic antioxidants show promise in preclinical studies in the therapy of cancer April 27, 2001
MMP-1-sparing MMP inhibitor demonstrates activity against lung, prostate and breast cancers April 27, 2001
Potential small-molecule cancer therapeutic designed at Agouron to be selective for VEGF RTK April 27, 2001
RSS